Tau Consortium

company

About

Tau Consortium’s mission is to accelerate the development of new treatments for Alzheimer’s disease.

Highlights

Details

Industries
Health Care,Non Profit
Founded date
Jan 1, 2009
Operating Status
Active

Tau Consortium is a collaborative research program that is managed and funded by the Rainwater Charitable Foundation in partnership with other funders.They commission world-class research and drug discovery to treat and prevent primary tauopathies like progressive supranuclear palsy, as well as secondary ones such as Alzheimer’s disease. They strategy is to engage and support talented researchers.

Investments

Number of Investments
Number of Lead Investments
1
0
Tau Consortium has made 1 investments. Their most recent investment was on Jan 17, 2019, when Aquinnah Pharmaceuticals raised $750K.
Date Company Name
Round Money Raised Industry Lead Investor
Grant $750K Health Care